X0202 4 2006-01-04 1 0001013351 MAXIM PHARMACEUTICALS INC MAXM 0001215912 MARTENSSON PEROLAF C/O MAXIM PHARMACEUTICALS, INC. 8899 UNIVERSITY CENTER LANE, SUITE 400 SAN DIEGO CA 92122 1 0 0 0 Common Stock 2006-01-04 4 D 0 333 D 0 D Employee Stock Option (Right to Buy) 37.00 2006-01-04 4 D 0 20000 0 D 2010-11-17 Common Stock 20000 0 D Employee Stock Option (Right to Buy) 72.50 2006-01-04 4 D 0 10000 0 D 2010-02-25 Common Stock 10000 0 D Employee Stock Option (Right to Buy) 8.00 2006-01-04 4 D 0 50000 D 2009-10-26 Common Stock 50000 0 D Employee Stock Option (Right to Buy) 6.94 2006-01-04 4 D 0 20000 D 2011-03-07 Common Stock 20000 0 D Employee Stock Option (Right to Buy) 6.94 2006-01-04 4 D 0 20000 D 2011-03-07 Common Stock 20000 0 D Employee Stock Option (Right to Buy) 5.73 2006-01-04 4 D 0 20000 D 2012-03-01 Common Stock 20000 0 D Employee Stock Option (Right to Buy) 9.60 2006-01-04 4 D 0 20000 D 2014-02-19 Common Stock 20000 0 D Employee Stock Option (Right to Buy) 9.60 2006-01-04 4 D 0 20000 D 2014-02-19 Common Stock 20000 0 D Employee Stock Option (Right to Buy) 3.25 2006-01-04 4 D 0 20000 D 2015-02-18 Common Stock 20000 0 D Employee Stock Option (Right to Buy) 1.64 2006-01-04 4 D 0 20000 D 2006-05-02 Common Stock 20000 0 D Employee Stock Option (Right to Buy) 3.75 2006-01-04 4 D 0 40000 D 2008-03-02 Common Stock 40000 0 D Employee Stock Option (Right to Buy) 15.75 2006-01-04 4 D 0 15000 D 2011-07-20 Common Stock 15000 0 D Employee Stock Option (Right to Buy) 5.20 2006-01-04 4 D 0 30000 D 2009-06-02 Common Stock 30000 0 D Employee Stock Option (Right to Buy) 9.25 2006-01-04 4 D 0 5000 D 2009-06-02 Common Stock 5000 0 D Disposed of pursuant to an Agreement and Plan of Merger among issuer, EpiCept Corporation and Magazine Acquisition Corp., dated September 6, 2005, in exchange for 0.203969 shares of EpiCept common stock and cash for fractional shares of EpiCept common stock equal to approximately $1.134 per share. Because there was no public market for the EpiCept common stock at the effective time of the merger, the market value of such stock was not determinable. This option was cancelled pursuant to an Agreement and Plan of Merger among issuer, EpiCept Corporation and Magazine Acquisition Corp., dated September 6, 2005. The option vested 100% on date of Grant. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 10,198 shares of EpiCept common stock for $39.23 per share. The option vested 100% on date of Grant. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $34.03 per share. The option vested 100% on 9/30/01. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $34.03 per share. The option vested 100% on 9/30/02. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $28.10 per share. The option vested 100% on date of Grant. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $47.07 per share. The option vested 100% on 9/30/04. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $47.07 per share. The option vested 100% on 9/30/03. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $15.94 per share. The option vested 100% on 9/30/05. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $8.05 per share. The option vested 100% on date of Grant. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 8,158 shares of EpiCept common stock for $18.39 per share. The option vested 100% on date of Grant. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 3,059 shares of EpiCept common stock for $77.22 per share. The option vested 100% on date of Grant. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 6,119 shares of EpiCept common stock for $25.50 per share. The option vested 100% on date of Grant. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 1,019 shares of EpiCept common stock for $45.36 per share. /s/ John D. Prunty Attorney-in-Fact 2006-01-06